glp-1-receptoragonister GLP-1 Agonists: A Comprehensive Overview GLP-1 receptor agonists for individualized
Description
Pharmacokinetics, pharmacodynamics, tolerability, and safety of exenatide in Japanese patients with type 2 diabetes mellitus
The IRRs of pancreatic cancer (0.74), thyroid cancer (1.32), and medullary thyroid cancer (0.34) did not significantly increase in the GLP-1 RA group compared with those in the DM control group
Peptide-based GLP-1/glucagon co-agonists: a double-edged sword to combat diabesity
Debose-Boyd RA, Ye J
Below are the some GLP-1 medications available in the market currently
Nausea, constipation, fatigue, and digestive discomfort are frequently reported
